Physicians Financial Services Inc. Has $2,640,000 Stake in Chevron Corp. (CVX)
Physicians Financial Services Inc. increased its position in shares of Chevron Corp. (NYSE:CVX) by 2.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 25,185 shares of the company’s stock after buying an additional 541 shares during the period. Chevron Corp. makes up 2.3% of Physicians Financial Services Inc.’s investment portfolio, making the stock its 7th largest position. Physicians Financial Services Inc.’s holdings in Chevron Corp. were worth $2,640,000 as of its most recent filing with the SEC.
Several other large investors also recently modified their holdings of the stock. RPg Family Wealth Advisory LLC raised its stake in shares of Chevron Corp. by 14.5% in the first quarter. RPg Family Wealth Advisory LLC now owns 1,058 shares of the company’s stock worth $101,000 after buying an additional 134 shares during the period. Marshall & Sullivan Inc. WA raised its stake in shares of Chevron Corp. by 4.0% in the first quarter. Marshall & Sullivan Inc. WA now owns 1,825 shares of the company’s stock worth $174,000 after buying an additional 71 shares during the period. Carnick & Kubik LLC bought a new stake in shares of Chevron Corp. during the first quarter worth about $188,000. Exane Derivatives raised its stake in shares of Chevron Corp. by 57.3% in the first quarter. Exane Derivatives now owns 1,994 shares of the company’s stock worth $190,000 after buying an additional 726 shares during the period. Finally, Stillwater Capital Advisors LLC bought a new stake in shares of Chevron Corp. during the second quarter worth about $204,000. Institutional investors and hedge funds own 62.26% of the company’s stock.
Chevron Corp. (NYSE:CVX) traded down 1.67% during midday trading on Friday, reaching $97.84. 12,725,620 shares of the company’s stock were exchanged. Chevron Corp. has a 1-year low of $75.10 and a 1-year high of $107.58. The firm’s 50-day moving average is $101.60 and its 200 day moving average is $100.07. The stock’s market cap is $184.58 billion.
Chevron Corp. (NYSE:CVX) last announced its earnings results on Friday, July 29th. The company reported ($0.78) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.32 by $1.10. Chevron Corp. had a positive return on equity of 1.07% and a negative net margin of 0.64%. The company earned $29.28 billion during the quarter, compared to the consensus estimate of $25.78 billion. During the same period in the prior year, the firm posted $0.30 earnings per share. The company’s revenue was down 27.4% on a year-over-year basis. Equities analysts anticipate that Chevron Corp. will post $1.29 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Monday, September 12th. Shareholders of record on Friday, August 19th were paid a $1.07 dividend. This represents a $4.28 dividend on an annualized basis and a dividend yield of 4.37%. The ex-dividend date was Wednesday, August 17th. Chevron Corp.’s dividend payout ratio is presently -1,097.44%.
A number of equities research analysts have recently issued reports on the stock. Vetr lowered shares of Chevron Corp. from a “buy” rating to a “hold” rating and set a $105.55 target price on the stock. in a research note on Wednesday, May 25th. Credit Suisse Group AG restated a “hold” rating and issued a $100.00 target price on shares of Chevron Corp. in a research note on Thursday, June 2nd. Zacks Investment Research lowered shares of Chevron Corp. from a “buy” rating to a “hold” rating in a research note on Wednesday, August 3rd. Piper Jaffray Cos. upgraded shares of Chevron Corp. from a “neutral” rating to an “overweight” rating and upped their target price for the company from $110.00 to $117.00 in a research note on Tuesday, August 9th. Finally, Morgan Stanley reiterated a “hold” rating and set a $85.00 price objective on shares of Chevron Corp. in a research note on Wednesday, June 8th. Thirteen investment analysts have rated the stock with a hold rating and nineteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $102.01.
In other news, insider Michael K. Wirth sold 125,000 shares of Chevron Corp. stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $100.47, for a total transaction of $12,558,750.00. Following the completion of the sale, the insider now owns 4,222 shares in the company, valued at approximately $424,184.34. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Pierre R. Breber sold 21,000 shares of Chevron Corp. stock in a transaction that occurred on Tuesday, August 2nd. The stock was sold at an average price of $98.77, for a total transaction of $2,074,170.00. The disclosure for this sale can be found here. 0.40% of the stock is currently owned by company insiders.
Chevron Corp. Company Profile
Chevron Corporation (Chevron) manages its investments in subsidiaries and affiliates and provides administrative, financial, management and technology support to the United States and international subsidiaries that engage in integrated energy and chemicals operations. The Company operates through two business segments: Upstream and Downstream.
Want to see what other hedge funds are holding CVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chevron Corp. (NYSE:CVX).
Receive News & Ratings for Chevron Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chevron Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.